SG148997A1 - Powders comprising low molecular dextran and methods of producing those powders - Google Patents

Powders comprising low molecular dextran and methods of producing those powders

Info

Publication number
SG148997A1
SG148997A1 SG200808989-8A SG2008089898A SG148997A1 SG 148997 A1 SG148997 A1 SG 148997A1 SG 2008089898 A SG2008089898 A SG 2008089898A SG 148997 A1 SG148997 A1 SG 148997A1
Authority
SG
Singapore
Prior art keywords
powders
methods
low molecular
molecular dextran
producing those
Prior art date
Application number
SG200808989-8A
Other languages
English (en)
Inventor
Karoline Bechtold-Peters
Wolfgang Friess
Richard Fuhrherr
Stefan Bassarab
Patrick Garidel
Torsten Schultz-Fademrecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of SG148997A1 publication Critical patent/SG148997A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SG200808989-8A 2003-12-13 2004-12-08 Powders comprising low molecular dextran and methods of producing those powders SG148997A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10358387A DE10358387A1 (de) 2003-12-13 2003-12-13 Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SG148997A1 true SG148997A1 (en) 2009-01-29

Family

ID=34638656

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200808989-8A SG148997A1 (en) 2003-12-13 2004-12-08 Powders comprising low molecular dextran and methods of producing those powders

Country Status (8)

Country Link
EP (1) EP1694306B1 (enExample)
JP (1) JP2007514664A (enExample)
KR (1) KR20070014113A (enExample)
CA (1) CA2548132A1 (enExample)
DE (1) DE10358387A1 (enExample)
SG (1) SG148997A1 (enExample)
TW (1) TW200529863A (enExample)
WO (1) WO2005055976A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2074141B1 (en) 2006-09-22 2016-08-10 Novo Nordisk A/S Protease resistant insulin analogues
CN101622302B (zh) 2007-01-26 2013-01-23 Isp投资公司 生产喷雾干燥产品的制剂工艺方法
WO2008132224A2 (en) 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
CN101970477B (zh) 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
PT2910570T (pt) 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
WO2010132827A1 (en) * 2009-05-15 2010-11-18 Bend Research, Inc. Low-molecular dextran for powder inhalations
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
WO2012031129A2 (en) 2010-09-03 2012-03-08 Bend Research, Inc. Spray-drying apparatus and methods of using the same
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
PT2691415T (pt) * 2011-03-28 2018-10-19 Ablynx Nv Método para produção de formulações sólidas compreendendo domínios variáveis únicos de imunoglobulina
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
CA2836643C (en) * 2011-05-19 2017-11-14 Savara, Inc. Dry powder vancomycin compositions and associated methods
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
PT3055325T (pt) 2013-10-07 2018-04-06 Novo Nordisk As Novo derivado de um análogo de insulina
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
PL3139979T3 (pl) 2014-05-07 2023-12-27 Boehringer Ingelheim International Gmbh Jednostka, nebulizator i sposób
TWI607770B (zh) 2014-05-07 2017-12-11 百靈佳殷格翰國際股份有限公司 噴霧器及其容器
JP6650933B2 (ja) 2014-10-31 2020-02-19 ベンド リサーチ， インコーポレイテッド マトリックス中に分散された活性薬剤ドメインを形成するためのプロセス
CN107106641B (zh) 2014-10-31 2021-12-21 葛兰素史密斯克莱知识产权发展有限公司 粉末制剂
PT3554534T (pt) 2016-12-16 2021-11-05 Novo Nordisk As Composições farmacêuticas contendo insulina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666028B1 (en) * 1999-10-29 2010-03-24 Novartis AG Dry powder compositions having improved dispersivity
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
WO2003094887A1 (en) * 2002-05-09 2003-11-20 Peptron Co., Ltd Sustained release formulation of protein and preparation method thereof

Also Published As

Publication number Publication date
WO2005055976A3 (de) 2006-02-16
DE10358387A1 (de) 2005-07-07
CA2548132A1 (en) 2005-06-23
EP1694306B1 (de) 2018-09-12
WO2005055976A2 (de) 2005-06-23
JP2007514664A (ja) 2007-06-07
EP1694306A2 (de) 2006-08-30
TW200529863A (en) 2005-09-16
KR20070014113A (ko) 2007-01-31

Similar Documents

Publication Publication Date Title
SG148997A1 (en) Powders comprising low molecular dextran and methods of producing those powders
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
HUP0401534A2 (hu) Módosított humán IX. faktor
WO2006085983A3 (en) Viral adjuvants
WO2002101412A3 (en) Spray freeze-dried compositions
WO2011027257A3 (en) Pcsk9 vaccine
TWI265812B (en) Pharmaceutical safety dosage forms
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
UA96922C2 (en) Il-12/p40 binding protein
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
TNSN07341A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
AU2002316820A1 (en) Powder inhaler formulations
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
WO2006058539A3 (en) Growth hormone secretagogue receptor 1a ligands
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
SG135189A1 (en) High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
WO2003039592A3 (de) Zelluläre impfstoffe mit adjuvanzien
MXPA05010613A (es) Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo.
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2001068676A3 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей